OXTRIPHYLLINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for oxtriphylline and what is the scope of freedom to operate?
Oxtriphylline
is the generic ingredient in four branded drugs marketed by Parke Davis, Morton Grove, Watson Labs, and Warner Chilcott Llc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.Summary for OXTRIPHYLLINE
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 4 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 3,007 |
| DailyMed Link: | OXTRIPHYLLINE at DailyMed |
US Patents and Regulatory Information for OXTRIPHYLLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warner Chilcott Llc | CHOLEDYL SA | oxtriphylline | TABLET, EXTENDED RELEASE;ORAL | 086742-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | OXTRIPHYLLINE | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 087835-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Morton Grove | OXTRIPHYLLINE | oxtriphylline | SOLUTION;ORAL | 088243-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parke Davis | CHOLEDYL | oxtriphylline | SYRUP;ORAL | 009268-011 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
